FDA 'Remains Concerned' Certain Birth-Control Pills Have Clot Risk

The Food and Drug Administration issued a statement Monday saying in an ongoing review of a number of studies, it has not yet reached a conclusion about the blood clot risk in certain brands of birth-control pills, but the agency "remains concerned" that the risk is too high.  The FDA is tracking a number of  birth-control pill brands that contain drospirenone, a form of the synthetic hormone progestin.  The brands include Yaz (generics Gianvi and Loryna), Yasmin (generics Ocella, Syeda, and Zarah), Beyaz, and Safyral

The FDA plans to convene an expert panel in December to discuss the issue further but advises women taking birth control pills with drospirenone not to stop the product before talking to their doctors first. All pill users should be aware of blood clot symptoms -- persistent leg pain, severe chest pain, or sudden shortness of breath. And those who smoke and are over 35 years old should avoid oral contraceptives altogether since the combination of all three can significantly increase the risk of serious cardiovascular complications including blood clots.


Be the first to comment!

Parents may receive compensation when you click through and purchase from links contained on this website.